123 related articles for article (PubMed ID: 24374196)
1. Mechanistic insights into the analgesic efficacy of A-1264087, a novel neuronal Ca(2+) channel blocker that reduces nociception in rat preclinical pain models.
Zhu CZ; Vortherms TA; Zhang M; Xu J; Swensen AM; Niforatos W; Neelands T; Milicic I; Lewis LG; Zhong C; Gauvin D; Mikusa J; Zhan C; Pai M; Roderwald V; Chu KL; Cole EE; Bespalov A; Searle XB; McGaraughty S; Bitner RS; Jarvis MF; Bannon AW; Joshi SK; Scott VE; Lee CH
J Pain; 2014 Apr; 15(4):387.e1-14. PubMed ID: 24374196
[TBL] [Abstract][Full Text] [Related]
2. A mixed Ca2+ channel blocker, A-1264087, utilizes peripheral and spinal mechanisms to inhibit spinal nociceptive transmission in a rat model of neuropathic pain.
Xu J; Chu KL; Zhu CZ; Niforatos W; Swensen A; Searle X; Lee L; Jarvis MF; McGaraughty S
J Neurophysiol; 2014 Jan; 111(2):394-404. PubMed ID: 24155005
[TBL] [Abstract][Full Text] [Related]
3. Analgesic effects of a substituted N-triazole oxindole (TROX-1), a state-dependent, voltage-gated calcium channel 2 blocker.
Abbadie C; McManus OB; Sun SY; Bugianesi RM; Dai G; Haedo RJ; Herrington JB; Kaczorowski GJ; Smith MM; Swensen AM; Warren VA; Williams B; Arneric SP; Eduljee C; Snutch TP; Tringham EW; Jochnowitz N; Liang A; Euan MacIntyre D; McGowan E; Mistry S; White VV; Hoyt SB; London C; Lyons KA; Bunting PB; Volksdorf S; Duffy JL
J Pharmacol Exp Ther; 2010 Aug; 334(2):545-55. PubMed ID: 20439438
[TBL] [Abstract][Full Text] [Related]
4. A peripherally acting, selective T-type calcium channel blocker, ABT-639, effectively reduces nociceptive and neuropathic pain in rats.
Jarvis MF; Scott VE; McGaraughty S; Chu KL; Xu J; Niforatos W; Milicic I; Joshi S; Zhang Q; Xia Z
Biochem Pharmacol; 2014 Jun; 89(4):536-44. PubMed ID: 24726441
[TBL] [Abstract][Full Text] [Related]
5. A-1048400 is a novel, orally active, state-dependent neuronal calcium channel blocker that produces dose-dependent antinociception without altering hemodynamic function in rats.
Scott VE; Vortherms TA; Niforatos W; Swensen AM; Neelands T; Milicic I; Banfor PN; King A; Zhong C; Simler G; Zhan C; Bratcher N; Boyce-Rustay JM; Zhu CZ; Bhatia P; Doherty G; Mack H; Stewart AO; Jarvis MF
Biochem Pharmacol; 2012 Feb; 83(3):406-18. PubMed ID: 22153861
[TBL] [Abstract][Full Text] [Related]
6. Analgesic (omega)-conotoxins CVIE and CVIF selectively and voltage-dependently block recombinant and native N-type calcium channels.
Berecki G; Motin L; Haythornthwaite A; Vink S; Bansal P; Drinkwater R; Wang CI; Moretta M; Lewis RJ; Alewood PF; Christie MJ; Adams DJ
Mol Pharmacol; 2010 Feb; 77(2):139-48. PubMed ID: 19892914
[TBL] [Abstract][Full Text] [Related]
7. The Cav2.3 calcium channel antagonist SNX-482 reduces dorsal horn neuronal responses in a rat model of chronic neuropathic pain.
Matthews EA; Bee LA; Stephens GJ; Dickenson AH
Eur J Neurosci; 2007 Jun; 25(12):3561-9. PubMed ID: 17610575
[TBL] [Abstract][Full Text] [Related]
8. Antinociceptive activity of α4β2* neuronal nicotinic receptor agonist A-366833 in experimental models of neuropathic and inflammatory pain.
Nirogi R; Jabaris SL; Jayarajan P; Abraham R; Shanmuganathan D; Rasheed MA; Royapalley PK; Goura V
Eur J Pharmacol; 2011 Oct; 668(1-2):155-62. PubMed ID: 21756895
[TBL] [Abstract][Full Text] [Related]
9. Selective N-type neuronal voltage-sensitive calcium channel blocker, SNX-111, produces spinal antinociception in rat models of acute, persistent and neuropathic pain.
Bowersox SS; Gadbois T; Singh T; Pettus M; Wang YX; Luther RR
J Pharmacol Exp Ther; 1996 Dec; 279(3):1243-9. PubMed ID: 8968347
[TBL] [Abstract][Full Text] [Related]
10. 5beta-reduced neuroactive steroids are novel voltage-dependent blockers of T-type Ca2+ channels in rat sensory neurons in vitro and potent peripheral analgesics in vivo.
Todorovic SM; Pathirathna S; Brimelow BC; Jagodic MM; Ko SH; Jiang X; Nilsson KR; Zorumski CF; Covey DF; Jevtovic-Todorovic V
Mol Pharmacol; 2004 Nov; 66(5):1223-35. PubMed ID: 15280444
[TBL] [Abstract][Full Text] [Related]
11. A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat.
Jarvis MF; Honore P; Shieh CC; Chapman M; Joshi S; Zhang XF; Kort M; Carroll W; Marron B; Atkinson R; Thomas J; Liu D; Krambis M; Liu Y; McGaraughty S; Chu K; Roeloffs R; Zhong C; Mikusa JP; Hernandez G; Gauvin D; Wade C; Zhu C; Pai M; Scanio M; Shi L; Drizin I; Gregg R; Matulenko M; Hakeem A; Gross M; Johnson M; Marsh K; Wagoner PK; Sullivan JP; Faltynek CR; Krafte DS
Proc Natl Acad Sci U S A; 2007 May; 104(20):8520-5. PubMed ID: 17483457
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of T-type Ca2+ channels in primary sensory neurons in spinal nerve injury.
Yue J; Liu L; Liu Z; Shu B; Zhang Y
Spine (Phila Pa 1976); 2013 Mar; 38(6):463-70. PubMed ID: 22972512
[TBL] [Abstract][Full Text] [Related]
13. A-887826 is a structurally novel, potent and voltage-dependent Na(v)1.8 sodium channel blocker that attenuates neuropathic tactile allodynia in rats.
Zhang XF; Shieh CC; Chapman ML; Matulenko MA; Hakeem AH; Atkinson RN; Kort ME; Marron BE; Joshi S; Honore P; Faltynek CR; Krafte DS; Jarvis MF
Neuropharmacology; 2010 Sep; 59(3):201-7. PubMed ID: 20566409
[TBL] [Abstract][Full Text] [Related]
14. KST5468, a new T-type calcium channel antagonist, has an antinociceptive effect on inflammatory and neuropathic pain models.
Lee MJ; Shin TJ; Lee JE; Choo H; Koh HY; Chung HJ; Pae AN; Lee SC; Kim HJ
Pharmacol Biochem Behav; 2010 Dec; 97(2):198-204. PubMed ID: 20678515
[TBL] [Abstract][Full Text] [Related]
15. Luminal hydrogen sulfide plays a pronociceptive role in mouse colon.
Matsunami M; Tarui T; Mitani K; Nagasawa K; Fukushima O; Okubo K; Yoshida S; Takemura M; Kawabata A
Gut; 2009 Jun; 58(6):751-61. PubMed ID: 18852258
[TBL] [Abstract][Full Text] [Related]
16. Additive antinociceptive effects of the selective Nav1.8 blocker A-803467 and selective TRPV1 antagonists in rat inflammatory and neuropathic pain models.
Joshi SK; Honore P; Hernandez G; Schmidt R; Gomtsyan A; Scanio M; Kort M; Jarvis MF
J Pain; 2009 Mar; 10(3):306-15. PubMed ID: 19070548
[TBL] [Abstract][Full Text] [Related]
17. Effect of tetramethylpyrazine on primary afferent transmission mediated by P2X3 receptor in neuropathic pain states.
Gao Y; Xu C; Liang S; Zhang A; Mu S; Wang Y; Wan F
Brain Res Bull; 2008 Sep; 77(1):27-32. PubMed ID: 18639742
[TBL] [Abstract][Full Text] [Related]
18. Biochemical and pharmacological assessment of MAP-kinase signaling along pain pathways in experimental rodent models: a potential tool for the discovery of novel antinociceptive therapeutics.
Edelmayer RM; Brederson JD; Jarvis MF; Bitner RS
Biochem Pharmacol; 2014 Feb; 87(3):390-8. PubMed ID: 24300134
[TBL] [Abstract][Full Text] [Related]
19. An integrated multiassay approach to the discovery of small-molecule N-type voltage-gated calcium channel antagonists.
Finley MF; Lubin ML; Neeper MP; Beck E; Liu Y; Flores CM; Qin N
Assay Drug Dev Technol; 2010 Dec; 8(6):685-94. PubMed ID: 21050074
[TBL] [Abstract][Full Text] [Related]
20. Icilin reduces voltage-gated calcium channel currents in naïve and injured DRG neurons in the rat spinal nerve ligation model.
Hagenacker T; Lampe M; Schäfers M
Brain Res; 2014 Apr; 1557():171-9. PubMed ID: 24560602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
